KORU Medical Systems, Inc. · NASDAQ:KRMD

KORU Medical Systems, Inc. financial statements

KORU Medical Systems, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017
Revenue41.1M33.6M28.5M27.9M23.5M24.2M23.2M17.4M16.0M12.3M
Cost of revenue15.5M12.3M11.8M12.5M9.72M9.24M8.31M6.54M6.52M4.72M
Gross profit25.6M21.3M16.7M15.4M13.8M14.9M14.9M10.8M9.46M7.57M
Research and development4.39M5.26M5.74M4.96M2.47M1.30M740.5K241.1K60.7K237.5K
Selling, general and administrative23.4M21.6M20.4M20.6M17.9M12.0M9.77M8.20M7.73M7.77M
Operating income-2.97M-6.45M-10.3M-10.8M-7.03M-1.25M585.7K1.16M1.48M-736.3K
Depreciation and amortization810.5K888.5K870.4K587.1K463.1K418.6K340.2K309.3K308.7K300.6K
EBITDA-2.16M-5.56M-9.40M-10.2M-6.57M-836.2K925.9K1.47M1.79M-435.6K
Interest expense145.6K637.2K4.82M6.69M3.28K65.7K1.89K
Income before tax-2.62M-6.06M-9.77M-10.7M-6.36M1.19M696.4K1.18M1.57M-776.7K
Income tax21.9K2.89K3.97M-2.01M-1.80M-17.8K132.1K266.4K483.1K-241.7K
Net income-2.64M-6.07M-13.7M-8.66M-4.56M-1.21M564.3K910.6K1.09M-535.0K
Earnings per share, basic-0.06-0.13-0.30-0.19-0.10-0.030.010.020.03-0.01
Earnings per share, diluted-0.06-0.13-0.30-0.19-0.10-0.030.010.02-0.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017
Cash and equivalents8.87M9.58M11.5M17.4M25.3M27.3M5.87M3.74M3.97M3.31M
Short-term investments1.52M263.3K
Receivables6.21M5.72M4.05M3.56M3.59M2.57M3.23M1.43M1.86M1.50M
Inventory3.68M2.80M3.48M6.40M6.11M6.83M2.39M2.10M1.66M1.35M
Current assets20.0M19.1M20.3M29.8M37.3M37.5M11.9M9.03M7.93M6.78M
Property, plant and equipment4.47M4.29M3.84M3.89M1.11M1.17M611.8K858.8K836.3K932.1K
Total assets28.2M27.2M28.5M42.3M41.3M39.9M13.9M10.5M9.28M8.17M
Accounts payable2.27M1.65M975.2K2.39M1.23M624.9K572.7K453.5K454.4K772.4K
Current liabilities8.19M7.20M4.45M6.96M4.79M3.67M2.41M1.58M1.59M1.39M
Total debt3.50M3.99M4.45M4.93M604.1K239.5K381.7K
Total liabilities11.2M10.4M8.11M11.0M4.79M3.76M2.65M1.58M1.61M1.49M
Shareholders' equity17.0M16.8M20.4M31.3M36.5M36.2M11.2M8.96M7.67M6.68M
Shares outstanding46.4M46.0M45.7M45.4M44.6M43.3M39.5M38.2M38.4M37.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2017
Cash from operations462.4K-319.7K-4.89M-5.40M-4.32M-743.3K320.6K1.48M899.9K-331.6K
Capital spending-932.5K-1.30M-782.9K-2.76M-346.2K-920.6K-201.2K-297.0K-218.3K-203.1K
Free cash flow-470.1K-1.62M-5.68M-8.17M-4.67M-1.66M119.4K1.18M681.6K-534.7K
Cash from investing-949.8K-1.33M-814.6K-2.80M-366.2K-1.04M1.31M-1.73M-219.3K-416.3K
Cash from financing-221.3K-248.5K-218.9K279.5K2.71M23.2M501.3K14.4K-19.4K-140.7K
Dividends paid-184.8K
Share buybacks-97.4K406.6K0-3.50M-2.82K-36.8K-19.4K
Change in cash-708.7K-1.90M-5.93M-7.93M-1.98M21.4M2.13M-235.7K-227.4K-888.7K